Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

The safe and effective delivery of anticancer agents to diseased tissues is one of the
significant challenges in cancer therapy. Conventional anticancer agents are generally …

Human serum albumin (HSA)-based therapeutics have attracted tremendous attention in the
development of anticancer agents. The versatile properties of HSA make HSA-based …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …

Targeted liposomes are designed to target specific receptors overexpressed on the surfaces
of cancer cells. This technique ensures site-specific drug delivery to reduce undesirable side …

Delivering drugs to tumors using nanoparticles (NPs) has shown promising potential in
promoting targeted drug delivery of antineoplastic agents to enhance their efficiency while …

Inherited kidney diseases (IKDs) are a large group of disorders affecting different nephron
segments, many of which progress towards kidney failure due to the absence of curative …

The field of theranostics has been rapidly growing in recent years and nanotechnology has
played a major role in this growth. Nanomaterials can be constructed to respond to a variety …

Albumin, the most abundant protein in plasma, possesses some inherent beneficial
structural and physiological characteristics that make it suitable for use as a drug delivery …

Theranostic liposomes have recently found a broad range of applications in nanomedicine
due to stability, the high solubility of biomacromolecules, bioavailability, efficacy, and low …